Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.200
-0.050 (-4.00%)
At close: Feb 27, 2026, 4:00 PM EST
1.223
+0.023 (1.93%)
After-hours: Feb 27, 2026, 7:51 PM EST
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $2.86 million as of February 27, 2026. Its market cap has decreased by -53.52% in one year.
Market Cap
2.86M
Enterprise Value
-1.80M
1-Year Change
-53.52%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $2.86M, a decrease of -95.02%. That is a compound annual growth rate of -48.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 2.86M | 4.99% |
| Dec 31, 2025 | 2.73M | -0.99% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oragenics | 3.58M |
| Enveric Biosciences | 3.27M |
| Scinai Immunotherapeutics | 3.12M |
| HCW Biologics | 3.11M |
| Propanc Biopharma | 3.06M |
| Psyence Biomedical | 2.91M |
| XORTX Therapeutics | 2.91M |
| SciSparc | 2.82M |